Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 593

    1.

    Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.

    Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H, Setian N, Damiani D.

    Diabetes Care. 2005 Aug;28(8):1856-61.PMID: 16043723 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

    Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A.

    Am J Med. 2004 Sep 1;117(5):291-6.PMID: 15336577 [PubMed - indexed for MEDLINE]Related articles

    3.
    4.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.

    Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE.

    Diabetes Care. 2004 Aug;27(8):1873-8.PMID: 15277410 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

    Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J.

    Exp Clin Endocrinol Diabetes. 1998;106(3):168-72.PMID: 9710355 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.

    Noyes KJ, Crofton P, Bath LE, Holmes A, Stark L, Oxley CD, Kelnar CJ.

    Pediatr Diabetes. 2007 Jun;8(3):150-6.PMID: 17550425 [PubMed - indexed for MEDLINE]Related articles

    10.

    Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.

    Ersöz HO, Ukinc K, Köse M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS.

    Int J Clin Pract. 2006 Apr;60(4):429-33.PMID: 16620355 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.

    Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM.

    Diabetes Care. 1997 Sep;20(9):1347-52.PMID: 9283776 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

    Rassam AG, Zeise TM, Burge MR, Schade DS.

    Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treatment of type 1 diabetes with insulin lispro during Ramadan.

    Kadiri A, Al-Nakhi A, El-Ghazali S, Jabbar A, Al Arouj M, Akram J, Wyatt J, Assem A, Ristic S.

    Diabetes Metab. 2001 Sep;27(4 Pt 1):482-6.PMID: 11547222 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro.

    Johansson UB, Wredling R, Adamson U, Lins PE.

    Diabetes Metab. 2007 Dec;33(6):469-71. Epub 2007 Nov 26.PMID: 18032083 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

    Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S.

    Diabetes. 1999 Jan;48(1):99-105.PMID: 9892228 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

    Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, Semakula C, Umpierrez D, Peng L, Cerón M, Robalino G.

    Diabetes Care. 2009 Jul;32(7):1164-9. Epub 2009 Apr 14.PMID: 19366972 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Perioperative management with prolonged intravenous insulin infusion versus subcutaneous insulin in children with type I diabetes mellitus.

    Kaufman FR, Devgan S, Roe TF, Costin G.

    J Diabetes Complications. 1996 Jan-Feb;10(1):6-11.PMID: 8639976 [PubMed - indexed for MEDLINE]Related articles

    19.

    Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.

    Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern K, Angelkort B.

    Diabetes Care. 1999 May;22(5):674-7.PMID: 10332664 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients.

    Boullu-Sanchis S, Ortega F, Chabrier G, Busch MS, Uhl C, Pinget M, Jeandidier N.

    Diabetes Metab. 2006 Sep;32(4):350-7.PMID: 16977263 [PubMed - indexed for MEDLINE]Related articlesFree article